Influence of the solvent composition on the aerosol synthesis of pharmaceutical polymer nanoparticles
Spherical, Eudragit L100 polymer nanoparticles with and without a ketoprofen drug were prepared by a novel aerosol flow reactor method. In this method, the polymer solution is sprayed to form nanosized droplets followed by the evaporation of a solvent. A purpose of the work was to explore the effect...
Gespeichert in:
Veröffentlicht in: | International journal of pharmaceutics 2004-10, Vol.284 (1), p.13-21 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 21 |
---|---|
container_issue | 1 |
container_start_page | 13 |
container_title | International journal of pharmaceutics |
container_volume | 284 |
creator | Raula, Janne Eerikäinen, Hannele Kauppinen, Esko I. |
description | Spherical, Eudragit L100 polymer nanoparticles with and without a ketoprofen drug were prepared by a novel aerosol flow reactor method. In this method, the polymer solution is sprayed to form nanosized droplets followed by the evaporation of a solvent. A purpose of the work was to explore the effect of solvent, solvent mixture, and co-solute (ketoprofen) on the formation of polymer particle, and particularly on particle morphology. The solvents used, i.e. ethanol, THF, toluene, and water, were selected according to their vapor pressure and dissolution capability for the polymer. At the polymer concentration range from 0.2 to 1.5
g/l of the starting solution, the geometric number mean diameters (GMD) of the particles increased from 75 to 130
nm and from 65 to 100
nm from the solutions of ethanol and THF, respectively. Particle morphology was observed by a scanning electron microscope (SEM). Particles changed from collapsed to irregular via spherical shape in the course of the decreasing solubility of the polymer in the medium. This is critically dependent on the solvent evaporation rate as well as the solute solubility, i.e. fast evaporative removal of solvent results in collapsed particles whereas low solubility results in irregular particles. Interplay between the vapor pressure of the solvents and the polymer solubility in the medium made possible to prepare particles with more complicated structures such as shriveled and blistery structures. The particle morphology as detected by SEM did not change when 10
wt.% of ketoprofen was added to the precursor solution. |
doi_str_mv | 10.1016/j.ijpharm.2004.07.003 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_66925609</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0378517304004417</els_id><sourcerecordid>66925609</sourcerecordid><originalsourceid>FETCH-LOGICAL-c457t-19126ce1250ac64e057d53b63ac43640d509de9cc5d8484e6b0c5c5c15e028263</originalsourceid><addsrcrecordid>eNqFkU1r3DAQQEVpaDZpf0KDL-3NzujT9qmU0CYLgVzas9DKY6LFlhzJDuy_j9w15FgkENK8GY2eCPlKoaJA1e2xcsfp2cSxYgCigroC4B_IjjY1L7mo1UeyA143paQ1vyRXKR0BQDHKP5FLKoUUrGU7gnvfDwt6i0Xoi_kZixSGV_RzYcM4heRmF3yR5xoyGEMOF-nk8za5tOb8a8JYXGZnzVBMYTiNGAtvfJhMzIcDps_kojdDwi_bek3-_v715-6hfHy639_9fCytkPVc0pYyZZEyCcYqgSDrTvKD4sYKrgR0EtoOW2tl14hGoDqAlXlQicAapvg1-X6uO8XwsmCa9eiSxWEwHsOStFItkwraDMozaPOLUsReT9GNJp40Bb361Ue9-dWrXw21zn5z3s12wXIYsXvP2oRm4NsGmJR19NF469I7p2hDOYPM_ThzmHW8Oow6Wbd-Q-ci2ll3wf2nlTcIqp03</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>66925609</pqid></control><display><type>article</type><title>Influence of the solvent composition on the aerosol synthesis of pharmaceutical polymer nanoparticles</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Raula, Janne ; Eerikäinen, Hannele ; Kauppinen, Esko I.</creator><creatorcontrib>Raula, Janne ; Eerikäinen, Hannele ; Kauppinen, Esko I.</creatorcontrib><description>Spherical, Eudragit L100 polymer nanoparticles with and without a ketoprofen drug were prepared by a novel aerosol flow reactor method. In this method, the polymer solution is sprayed to form nanosized droplets followed by the evaporation of a solvent. A purpose of the work was to explore the effect of solvent, solvent mixture, and co-solute (ketoprofen) on the formation of polymer particle, and particularly on particle morphology. The solvents used, i.e. ethanol, THF, toluene, and water, were selected according to their vapor pressure and dissolution capability for the polymer. At the polymer concentration range from 0.2 to 1.5
g/l of the starting solution, the geometric number mean diameters (GMD) of the particles increased from 75 to 130
nm and from 65 to 100
nm from the solutions of ethanol and THF, respectively. Particle morphology was observed by a scanning electron microscope (SEM). Particles changed from collapsed to irregular via spherical shape in the course of the decreasing solubility of the polymer in the medium. This is critically dependent on the solvent evaporation rate as well as the solute solubility, i.e. fast evaporative removal of solvent results in collapsed particles whereas low solubility results in irregular particles. Interplay between the vapor pressure of the solvents and the polymer solubility in the medium made possible to prepare particles with more complicated structures such as shriveled and blistery structures. The particle morphology as detected by SEM did not change when 10
wt.% of ketoprofen was added to the precursor solution.</description><identifier>ISSN: 0378-5173</identifier><identifier>EISSN: 1873-3476</identifier><identifier>DOI: 10.1016/j.ijpharm.2004.07.003</identifier><identifier>PMID: 15454292</identifier><identifier>CODEN: IJPHDE</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>Aerosol ; Aerosols - chemical synthesis ; Biological and medical sciences ; Chemistry, Pharmaceutical ; Drug ; Eudragit ; General pharmacology ; Medical sciences ; Nanoparticles ; Nanostructures - chemistry ; Pharmaceutical technology. Pharmaceutical industry ; Pharmacology. Drug treatments ; Polymer ; Polymers - chemical synthesis ; Solvents - chemistry</subject><ispartof>International journal of pharmaceutics, 2004-10, Vol.284 (1), p.13-21</ispartof><rights>2004 Elsevier B.V.</rights><rights>2004 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c457t-19126ce1250ac64e057d53b63ac43640d509de9cc5d8484e6b0c5c5c15e028263</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ijpharm.2004.07.003$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,777,781,3537,27905,27906,45976</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16181320$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15454292$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Raula, Janne</creatorcontrib><creatorcontrib>Eerikäinen, Hannele</creatorcontrib><creatorcontrib>Kauppinen, Esko I.</creatorcontrib><title>Influence of the solvent composition on the aerosol synthesis of pharmaceutical polymer nanoparticles</title><title>International journal of pharmaceutics</title><addtitle>Int J Pharm</addtitle><description>Spherical, Eudragit L100 polymer nanoparticles with and without a ketoprofen drug were prepared by a novel aerosol flow reactor method. In this method, the polymer solution is sprayed to form nanosized droplets followed by the evaporation of a solvent. A purpose of the work was to explore the effect of solvent, solvent mixture, and co-solute (ketoprofen) on the formation of polymer particle, and particularly on particle morphology. The solvents used, i.e. ethanol, THF, toluene, and water, were selected according to their vapor pressure and dissolution capability for the polymer. At the polymer concentration range from 0.2 to 1.5
g/l of the starting solution, the geometric number mean diameters (GMD) of the particles increased from 75 to 130
nm and from 65 to 100
nm from the solutions of ethanol and THF, respectively. Particle morphology was observed by a scanning electron microscope (SEM). Particles changed from collapsed to irregular via spherical shape in the course of the decreasing solubility of the polymer in the medium. This is critically dependent on the solvent evaporation rate as well as the solute solubility, i.e. fast evaporative removal of solvent results in collapsed particles whereas low solubility results in irregular particles. Interplay between the vapor pressure of the solvents and the polymer solubility in the medium made possible to prepare particles with more complicated structures such as shriveled and blistery structures. The particle morphology as detected by SEM did not change when 10
wt.% of ketoprofen was added to the precursor solution.</description><subject>Aerosol</subject><subject>Aerosols - chemical synthesis</subject><subject>Biological and medical sciences</subject><subject>Chemistry, Pharmaceutical</subject><subject>Drug</subject><subject>Eudragit</subject><subject>General pharmacology</subject><subject>Medical sciences</subject><subject>Nanoparticles</subject><subject>Nanostructures - chemistry</subject><subject>Pharmaceutical technology. Pharmaceutical industry</subject><subject>Pharmacology. Drug treatments</subject><subject>Polymer</subject><subject>Polymers - chemical synthesis</subject><subject>Solvents - chemistry</subject><issn>0378-5173</issn><issn>1873-3476</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU1r3DAQQEVpaDZpf0KDL-3NzujT9qmU0CYLgVzas9DKY6LFlhzJDuy_j9w15FgkENK8GY2eCPlKoaJA1e2xcsfp2cSxYgCigroC4B_IjjY1L7mo1UeyA143paQ1vyRXKR0BQDHKP5FLKoUUrGU7gnvfDwt6i0Xoi_kZixSGV_RzYcM4heRmF3yR5xoyGEMOF-nk8za5tOb8a8JYXGZnzVBMYTiNGAtvfJhMzIcDps_kojdDwi_bek3-_v715-6hfHy639_9fCytkPVc0pYyZZEyCcYqgSDrTvKD4sYKrgR0EtoOW2tl14hGoDqAlXlQicAapvg1-X6uO8XwsmCa9eiSxWEwHsOStFItkwraDMozaPOLUsReT9GNJp40Bb361Ue9-dWrXw21zn5z3s12wXIYsXvP2oRm4NsGmJR19NF469I7p2hDOYPM_ThzmHW8Oow6Wbd-Q-ci2ll3wf2nlTcIqp03</recordid><startdate>20041013</startdate><enddate>20041013</enddate><creator>Raula, Janne</creator><creator>Eerikäinen, Hannele</creator><creator>Kauppinen, Esko I.</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20041013</creationdate><title>Influence of the solvent composition on the aerosol synthesis of pharmaceutical polymer nanoparticles</title><author>Raula, Janne ; Eerikäinen, Hannele ; Kauppinen, Esko I.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c457t-19126ce1250ac64e057d53b63ac43640d509de9cc5d8484e6b0c5c5c15e028263</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Aerosol</topic><topic>Aerosols - chemical synthesis</topic><topic>Biological and medical sciences</topic><topic>Chemistry, Pharmaceutical</topic><topic>Drug</topic><topic>Eudragit</topic><topic>General pharmacology</topic><topic>Medical sciences</topic><topic>Nanoparticles</topic><topic>Nanostructures - chemistry</topic><topic>Pharmaceutical technology. Pharmaceutical industry</topic><topic>Pharmacology. Drug treatments</topic><topic>Polymer</topic><topic>Polymers - chemical synthesis</topic><topic>Solvents - chemistry</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Raula, Janne</creatorcontrib><creatorcontrib>Eerikäinen, Hannele</creatorcontrib><creatorcontrib>Kauppinen, Esko I.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of pharmaceutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Raula, Janne</au><au>Eerikäinen, Hannele</au><au>Kauppinen, Esko I.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Influence of the solvent composition on the aerosol synthesis of pharmaceutical polymer nanoparticles</atitle><jtitle>International journal of pharmaceutics</jtitle><addtitle>Int J Pharm</addtitle><date>2004-10-13</date><risdate>2004</risdate><volume>284</volume><issue>1</issue><spage>13</spage><epage>21</epage><pages>13-21</pages><issn>0378-5173</issn><eissn>1873-3476</eissn><coden>IJPHDE</coden><abstract>Spherical, Eudragit L100 polymer nanoparticles with and without a ketoprofen drug were prepared by a novel aerosol flow reactor method. In this method, the polymer solution is sprayed to form nanosized droplets followed by the evaporation of a solvent. A purpose of the work was to explore the effect of solvent, solvent mixture, and co-solute (ketoprofen) on the formation of polymer particle, and particularly on particle morphology. The solvents used, i.e. ethanol, THF, toluene, and water, were selected according to their vapor pressure and dissolution capability for the polymer. At the polymer concentration range from 0.2 to 1.5
g/l of the starting solution, the geometric number mean diameters (GMD) of the particles increased from 75 to 130
nm and from 65 to 100
nm from the solutions of ethanol and THF, respectively. Particle morphology was observed by a scanning electron microscope (SEM). Particles changed from collapsed to irregular via spherical shape in the course of the decreasing solubility of the polymer in the medium. This is critically dependent on the solvent evaporation rate as well as the solute solubility, i.e. fast evaporative removal of solvent results in collapsed particles whereas low solubility results in irregular particles. Interplay between the vapor pressure of the solvents and the polymer solubility in the medium made possible to prepare particles with more complicated structures such as shriveled and blistery structures. The particle morphology as detected by SEM did not change when 10
wt.% of ketoprofen was added to the precursor solution.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>15454292</pmid><doi>10.1016/j.ijpharm.2004.07.003</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0378-5173 |
ispartof | International journal of pharmaceutics, 2004-10, Vol.284 (1), p.13-21 |
issn | 0378-5173 1873-3476 |
language | eng |
recordid | cdi_proquest_miscellaneous_66925609 |
source | MEDLINE; Elsevier ScienceDirect Journals Complete |
subjects | Aerosol Aerosols - chemical synthesis Biological and medical sciences Chemistry, Pharmaceutical Drug Eudragit General pharmacology Medical sciences Nanoparticles Nanostructures - chemistry Pharmaceutical technology. Pharmaceutical industry Pharmacology. Drug treatments Polymer Polymers - chemical synthesis Solvents - chemistry |
title | Influence of the solvent composition on the aerosol synthesis of pharmaceutical polymer nanoparticles |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T14%3A22%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Influence%20of%20the%20solvent%20composition%20on%20the%20aerosol%20synthesis%20of%20pharmaceutical%20polymer%20nanoparticles&rft.jtitle=International%20journal%20of%20pharmaceutics&rft.au=Raula,%20Janne&rft.date=2004-10-13&rft.volume=284&rft.issue=1&rft.spage=13&rft.epage=21&rft.pages=13-21&rft.issn=0378-5173&rft.eissn=1873-3476&rft.coden=IJPHDE&rft_id=info:doi/10.1016/j.ijpharm.2004.07.003&rft_dat=%3Cproquest_cross%3E66925609%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=66925609&rft_id=info:pmid/15454292&rft_els_id=S0378517304004417&rfr_iscdi=true |